Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.
about
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerA 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.Docetaxel in advanced gastric cancer--review of the main clinical trials.Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future.Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis.Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
P2860
Q28350903-6AE32990-1284-44A9-B023-7CC23619FF15Q33341214-193233AF-FA27-48A0-8226-C7A328ECE8E0Q33343001-ACE5333E-48FC-4D5D-B737-1439BC953419Q33411751-505337D1-38FC-40BD-8A08-B0BDBA11527DQ34960580-77F65672-D95E-495E-B05A-0287DCAD9753Q35208183-867127EE-E489-463F-B03F-8113F96B24C5Q35456754-6EC1D9E1-8269-40B7-BE12-E91E0A7CAC6DQ35613504-301729C6-0BB9-417A-A3BE-6D6EBAB60C40Q37008871-3DB1260A-476C-4466-A021-FC64CF27C71BQ38097969-1005AAEA-6E47-4495-A0A1-2F3F66C47C45Q40591941-A7C2E147-EFEF-4B75-86D7-CBD999425EA3Q55070614-204A1808-BD19-4C20-BFD9-77458F8DCC26
P2860
Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@ast
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@en
type
label
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@ast
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@en
prefLabel
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@ast
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@en
P356
P1433
P1476
Is òne cycle every three or fo ...... emotherapy in solid neoplasms.
@en
P2093
P304
P356
10.1023/A:1008344014518
P577
2000-02-01T00:00:00Z